You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 149 No. 2, February 1989 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Limitations to the Use of a Sensitive Assay for Serum Thyrotropin in the Assessment of Thyroid Status

David A. Ehrmann, MD; Michael Weinberg; David H. Same, MD

Arch Intern Med. 1989;149(2):369-372.


Abstract

• In the majority of clinical settings, a suppressed serum thyrotropin (s-TSH) level determined by the new sensitive assays is diagnostic of thyrotoxicosis. This has led to its proposed use as a screen for thyroid disease. However, s-TSH may be suppressed in conditions other than thyrotoxicosis. We retrospectively reviewed s-TSH measurements made in a large heterogeneous population to determine in which settings a suppressed value could potentially lead to misdiagnosis. We found that a suppressed s-TSH level was useful in making the diagnosis of autonomous thyroid function and in the assessment of thyroid hormone replacement therapy in patients with primary, but not central, hypothyroidism. Hyperthyroidism caused by either intrinsic thyroid disease or thyroid hormone administration accounted for 83% (111/134) of suppressed values; however, central hypothyroidism, nonthyroidal illness, acute psychiatric illness, or the administration of medication was responsible for this finding in 17% (23/134). While a suppressed s-TSH level is generally excellent in the diagnosis of pituitary suppression by thyroid hormone, in specific clinical settings, a suppressed s-TSH level may be seen in the absence of thyroid hormone excess. The limitations of its use as a first-line screen in those conditions must be recognized.

(Arch Intern Med 1989;149:369-372)



Author Affiliations

From the Thyroid Study Unit and the Thyroid Function Laboratory, Department of Medicine, The University of Chicago Pritzker School of Medicine. Dr Same is now with the University of Illinois at Chicago.


Footnotes

Accepted for publication Aug 5, 1988.

Presented in part at the 69th annual meeting of The Endocrine Society, Anaheim, Calif, June 11, 1987.

Reprint requests to University of Chicago, Thyroid Study Unit, Box 138, 5841 S Maryland Ave, Chicago, IL 60637 (Dr Ehrmann).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sensitive Thyrotropin and Free Thyroxine Testing in Outpatients: Are Both Necessary?
Bauer and Brown
Arch Intern Med 1996;156:2333-2337.
ABSTRACT  

Clinical Significance of Low Serum Thyrotropin Concentration by Chemiluminometric Assay in 85-Year-Old Women and Men
Sundbeck et al.
Arch Intern Med 1991;151:549-556.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.